Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants

计划入组 10 人 · 首次发布于 2012 年 4 月 12 日

RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.

计划入组 391 人 · 首次发布于 2014 年 6 月 26 日

Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response

计划入组 100 人 · 首次发布于 2015 年 5 月 7 日

SMNH compounds (oral, norovirus infection) (Spring Bank Pharmaceuticals)

immunotherapy (nosocomial infections)

HIV infections(Salus)

Spero Therapeutics

United States

Telix Pharmaceuticals

Australia

Scynexis

United States

Inspira's Bio-Electronic Patch Shows 95% Efficacy in Preventing Bloodstream Infections

Two-Dose Dalbavancin Matches Standard Therapy for Complicated Staphylococcus aureus Bloodstream Infections

Cefiderocol Shows Non-Inferiority to Standard Therapy in Gram-Negative Bloodstream Infections